Ubiquitin-like modifier 1 ligating enzyme 1 relieves cisplatin-induced premature ovarian failure by reducing endoplasmic reticulum stress in granulosa cells

Reprod Biol Endocrinol. 2022 May 24;20(1):84. doi: 10.1186/s12958-022-00956-9.

Abstract

Background: Ubiquitin-like modifier 1 ligating enzyme 1 (UFL1), the ligase of the UFMylation system, has recently been reported to be involved in apoptosis and endoplasmic reticulum stress (ER stress) in a variety of diseases. Premature ovarian failure (POF) is a gynecological disease that severely reduces the fertility of women, especially in female cancer patients receiving chemotherapy drugs. Whether UFL1 is involved in protection against chemotherapy-induced POF and its mechanism remain unclear.

Methods: In this study, we examined the function of UFL1 in ovarian dysfunction and granulosa cell (GC) apoptosis induced by cisplatin through histological examination and cell viability analysis. We used western blotting, quantitative real-time PCR (qPCR) and immunofluorescence (IF) to detect the expression of UFL1 and the levels of ER stress specific markers. Enzyme linked immunosorbent assays were used to detect the levels of follicle-stimulating hormone (FSH) and estrogen (E2) in ovaries and GCs. In addition, we used infection with lentiviral particle suspensions to knock down and overexpress UFL1 in ovaries and GCs, respectively.

Results: Our data showed that the expression of UFL1 was reduced in POF model ovaries, accompanied by ER stress. In vitro, cisplatin induced a stress-related increase in UFL1 expression in GCs and enhanced ER stress, which was aggravated by UFL1 knockdown and alleviated by UFL1 overexpression. Furthermore, UFL1 knockdown resulted in a decrease in ovarian follicle number, an increase in atretic follicles, and decreased expression of AMH and FSHR. Conversely, the overexpression of UFL1 reduced cisplatin-induced damage to the ovary in vitro.

Conclusions: Our research indicated that UFL1 regulates cisplatin-induced ER stress and apoptosis in GCs, and participates in protection against cisplatin-induced POF, providing a potential therapeutic target for the clinical prevention of chemotherapeutic drug-induced POF.

Keywords: Apoptosis; Cisplatin; ER stress; GCs; POF; UFL1.

MeSH terms

  • Apoptosis
  • Cisplatin* / adverse effects
  • Endoplasmic Reticulum Stress* / drug effects
  • Female
  • Granulosa Cells / metabolism
  • Humans
  • Primary Ovarian Insufficiency* / chemically induced
  • Primary Ovarian Insufficiency* / metabolism
  • Primary Ovarian Insufficiency* / pathology
  • Ubiquitin-Protein Ligases* / metabolism
  • Ubiquitins / metabolism

Substances

  • Ubiquitins
  • Ubiquitin-Protein Ligases
  • UFL1 protein, human
  • Cisplatin